SOLUTION: Solved! For this assignment, choose a scholarly article containing a research study discussing the efficacy of a psychiatric treatment

For this assignment, choose a scholarly article containing a research study discussing the efficacy of a psychiatric treatment

For this assignment, choose a scholarly article containing a research study discussing the efficacy of a psychiatric treatment.

For this assignment, choose a scholarly article containing a research study discussing the efficacy of a psychiatric treatment. You can research a specific medication, a diagnostic rating scale, TMS, ECT, an integrative or alternative treatment (e.g., MDMA, psychedelics, an herbal supplement, etc.), or a medication augmentation strategy that is used in psychiatry.

In your Initial post:

Discuss the research study purpose, population, and how the study was conducted.
Explain the study findings and recommendations.
Analyze and discuss strengths and weaknesses of the study and whether you think the research supports the use of this intervention.
Support your opinion with at least one additional scholarly article.

      EXCELLENT  
   Based on 5 reviews 
    
 
 
 
   
 
 
       Posted on   
   
   Davis Onjoro 
 
 
 
 Trustindex verifies that the original source of the review is Google. Great service. Your tutors are awesome. Got an urgent paper worked on promptly and I received a great score. Will definitely contact you for more paper. Thank you!
  
 
      Posted on   
   
   Eugene Waliaula 
 
 
 
 Trustindex verifies that the original source of the review is Google. Brilliant, I am never disappointed with this service and have tried many. I now trust that I will receive a good writer as the service ensures they understand your requirements prior to delivery.
  
 
      Posted on   
   
   The Boogeyman 
 
 
 
 Trustindex verifies that the original source of the review is Google. Academic Research Bureau are the best in academic writing period!! Outstanding  work, with high quality essays, awesome support team and sensible prices.
  
 
      Posted on   
   
   Dark Child 
 
 
 
 Trustindex verifies that the original source of the review is Google. Excellent!! quick, delivers on time and good quality work. 100% recommend this guys.
  
 
      Posted on   
   
   Isaac Kiptoo 
 
 
 
 Trustindex verifies that the original source of the review is Google. Great Services, i ordered an essay from them and the results were amazing. Awesome support, will recommend them.
  
 
  
  
 
     Verified by Trustindex  Trustindex verified badge is the Universal Symbol of Trust. Only the greatest companies can get the verified badge who has a review score above 4.5, based on customer reviews over the past 12 months. Read more

Sample Expert Answer

Research Overview Discussion Board

Research Study Purpose, Population, and Study Design

The research study by Sackeim et al. (2020) aimed to evaluate the efficacy of Transcranial Magnetic Stimulation (TMS) as a treatment for Major Depressive Disorder (MDD) in a real-world clinical setting. TMS has been recognized as an effective treatment for MDD in randomized clinical trials, particularly for treatment-resistant cases. However, there is a need to better understand its efficacy in routine clinical practice, as well as to identify predictors of positive outcomes based on patient characteristics and treatment factors.

The study’s population consisted of 7,759 adult patients from 103 practice sites, with the intent-to-treat (ITT) sample including 5,010 individuals aged 18 or older, all diagnosed with MDD (Sackeim et al., 2020). The study used patient-rated (PHQ-9) and clinician-rated (CGI-S) clinical outcomes to assess treatment efficacy, measuring response and remission rates.

The study was conducted by collecting data from a registry that utilized the NeuroStar® Advanced Therapy System Clinical Outcomes Registry. Participants were required to complete a PHQ-9 assessment (a self-reported measure of depression severity) both before and after TMS treatment. Those included in the “completer” group had either responded to the treatment or completed 20 or more sessions with a final PHQ-9 assessment at the end of acute treatment (Sackeim et al., 2020). The clinician-rated CGI-S assessments were conducted for a smaller subset of participants.

Study Findings and Recommendations

The study reported highly favorable outcomes for TMS treatment in patients with MDD. Among the intent-to-treat (ITT) group, the response rates ranged between 58% and 83%, while the remission rates varied between 28% and 62%. These results were significant across both self-reported (PHQ-9) and clinician-administered (CGI-S) assessments (Sackeim et al., 2020). Certain factors were identified as predictors of more favorable outcomes.

For example, female patients and those who received a higher number of magnetic pulses per session exhibited superior clinical outcomes compared to others. Despite the voluntary participation of sites and the open-label design, the findings indicated that TMS had substantial clinical benefits in routine practice, comparable to or exceeding those of alternative treatments for treatment-resistant depression.

Strengths and Weaknesses of the Study

One of the primary strengths of this study is its large sample size, with over 7,000 participants contributing to robust and generalizable findings (Sackeim et al., 2020). Additionally, the use of real-world clinical data provides valuable insight into the practical application of TMS outside of controlled clinical trials, making the results highly relevant for healthcare providers who are considering TMS as a treatment option for their patients with MDD.

The inclusion of both self-reported and clinician-reported outcomes enhances the reliability of the findings by capturing multiple perspectives on treatment efficacy. The study also had several notable weaknesses (Sackeim et al., 2020). The voluntary participation of sites and the open-label design could introduce biases, as the healthcare providers involved may have had a vested interest in reporting positive outcomes.

Analysis

Overall, there is strong evidence supporting the use of TMS in treating MDD, particularly for patients who have not responded well to traditional treatments (Sackeim et al., 2020; Thompson, 2020). The significant response and remission rates observed in both self-reported and clinician-assessed outcomes suggest that TMS is a valuable treatment option for reducing depressive symptoms.

The study’s findings align with previous research on TMS, further validating its effectiveness in both clinical trials and real-world practice (Sackeim et al., 2020; Thompson, 2020). Future research should focus on addressing these limitations by conducting randomized controlled trials in real-world settings and examining the long-term effects of TMS.

References

Sackeim, H. A., Aaronson, S. T., Carpenter, L. L., Hutton, T. M., Mina, M., Pages, K., Verdoliva, S., & West, W. S. (2020). Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation. Journal of Affective Disorders, 277, 65-74. https://doi.org/10.1016/j.jad.2020.08.005

Thompson, L. (2020). Treating major depression and comorbid disorders with transcranial magnetic stimulation. Journal of Affective Disorders, 276, 453-460. https://doi.org/10.1016/j.jad.2020.07.025